新产品简介[Ad5-nCoV,新冠肺炎灭活疫苗(WIV04株),埃博拉病毒疫苗(rVSV-EBOV,活疫苗),JNJ-78436735,洛那法尼,马吉妥昔单抗,罗普司汀(新适应症),tenapanor(一级),替巴尼布林,托西珠单抗(新适应证),盐酸三唑昔单抗,ZF-2001]

A. Babu
{"title":"新产品简介[Ad5-nCoV,新冠肺炎灭活疫苗(WIV04株),埃博拉病毒疫苗(rVSV-EBOV,活疫苗),JNJ-78436735,洛那法尼,马吉妥昔单抗,罗普司汀(新适应症),tenapanor(一级),替巴尼布林,托西珠单抗(新适应证),盐酸三唑昔单抗,ZF-2001]","authors":"A. Babu","doi":"10.1358/DOT.2021.57.4.3295638","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"57 1","pages":"303"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New product intros [Ad5-nCoV, COVID-19 inactivated vaccine (WIV04 strain), Ebola virus vaccine (rVSV-EBOV, live), JNJ-78436735, lonafarnib, margetuximab, romiplostim (new indication), tenapanor (first-in-class), tirbanibulin, tocilizumab (new indication), trilaciclib hydrochloride, ZF-2001]\",\"authors\":\"A. Babu\",\"doi\":\"10.1358/DOT.2021.57.4.3295638\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":85144,\"journal\":{\"name\":\"Medicamentos de actualidad. Drugs of today\",\"volume\":\"57 1\",\"pages\":\"303\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicamentos de actualidad. Drugs of today\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1358/DOT.2021.57.4.3295638\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicamentos de actualidad. Drugs of today","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1358/DOT.2021.57.4.3295638","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
New product intros [Ad5-nCoV, COVID-19 inactivated vaccine (WIV04 strain), Ebola virus vaccine (rVSV-EBOV, live), JNJ-78436735, lonafarnib, margetuximab, romiplostim (new indication), tenapanor (first-in-class), tirbanibulin, tocilizumab (new indication), trilaciclib hydrochloride, ZF-2001]
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信